Literature DB >> 7036639

[Clinico-pharmacological observations of batroxobin (Defibrase) administered to normal human adults (author's transl)].

K Fukutake, M Fujimaki, H Nagasawa, M Kato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7036639

Source DB:  PubMed          Journal:  Nihon Ketsueki Gakkai Zasshi        ISSN： 0001-5806


× No keyword cloud information.
  4 in total

1.  The efficacy and safety of Batroxobin in combination with anticoagulation on cerebral venous sinus thrombosis.

Authors:  Jiayue Ding; Da Zhou; Yanyu Hu; Omar Elmadhoun; Liqun Pan; Jingyuan Ya; Tingting Geng; Zhongao Wang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

Review 2.  Clinical disorders of fibrinolysis: a critical review.

Authors:  R B Francis
Journal:  Blut       Date:  1989-07

3.  Batroxobin in combination with anticoagulation may promote venous sinus recanalization in cerebral venous thrombosis: A real-world experience.

Authors:  Jia-Yue Ding; Li-Qun Pan; Yan-Yu Hu; Gary B Rajah; Da Zhou; Chao-Bo Bai; Jing-Yuan Ya; Zhong-Ao Wang; Ke-Xin Jin; Jing-Wei Guan; Yu-Chuan Ding; Xun-Ming Ji; Ran Meng
Journal:  CNS Neurosci Ther       Date:  2019-01-23       Impact factor: 5.243

Review 4.  Use of Batroxobin in Central and Peripheral Ischemic Vascular Diseases: A Systematic Review.

Authors:  Duo Lan; Siying Song; Yunhuan Liu; Baolian Jiao; Ran Meng
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.